Clearmind Medicine Completes Dosing for All Participants in CMND-100 Trial
Clearmind Medicine announced the successful completion of dosing for all 24 participants in Cohorts 1 through 4 of Part A of its ongoing Phase I/II clinical trial evaluating CMND-100 for the treatment of Alcohol Use Disorder.
